Torrent Pharma Gets FDA Tentative Approval for Memantine Pill

Indian drugmaker Torrent Pharmaceuticals Ltd. (TRP) received tentative approval from the U.S. Food and Drug Administration for its memantine hydrochloride pill, the generic version of Forest Laboratories Inc. (FRX)’s Namenda medicine to treat Alzheimer’s disease, according to a statement on the regulator’s website.

To contact the reporter on this story: Adi Narayan in Mumbai at anarayan8@bloomberg.net

To contact the editor responsible for this story: Niveditha Ravi at nravi2@bloomberg.net

Bloomberg reserves the right to edit or remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.